FDA requests market withdrawal of all ranitidine products

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1799卷 / 1期

关键词：

D O I：

10.1007/s40278-020-77006-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[41] US FDA proposes terfenadine withdrawal
Reactions Weekly, 1997, 634 (1) : 2 - 2
[42] FDA announces voluntary withdrawal of pergolide
Rezendes, Allison
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2007, 230 (11): : 1616 - 1616
[43] FDA JOINS MARKET
GERSHON, D
NATURE, 1993, 364 (6433) : 93 - 93
[44] RESPONDING TO RECALL REQUESTS - A STRATEGY FOR MANAGING GOODS WITHDRAWAL
JACKSON, GC
MORGAN, FW
JOURNAL OF PUBLIC POLICY & MARKETING, 1988, 7 : 152 - 165
[45] Bringing Smart Pills to Market: FDA Regulation of Ingestible Drug/Device Combination Products
Avery, Matthew
Liu, Dan
FOOD AND DRUG LAW JOURNAL, 2011, 66 (03) : 329 - 352
[46] All ranitidine medications suspended in the EU
Reactions Weekly, 2020, 1804 (1) : 1 - 1
[47] FDA requests boxed warnings on older class of antipsychotic drugs
不详
PSYCHIATRIC ANNALS, 2008, 38 (07) : 436 - 436
[48] Market withdrawal of cisapride
Trenk, D
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 698 - 698
[49] IRRADIATED FOOD - FDA BLOCKS AEC ARMY REQUESTS FOR APPROVAL
JAMISON, A
SCIENCE, 1968, 161 (3837) : 146 - &
[50] FDA Written Requests: Identified Trends in Timelines and Drug Types
Barone, A.
Casey, D.
Reaman, G.
PEDIATRIC BLOOD & CANCER, 2017, 64 : S340 - S341

← 1 2 3 4 5 →